$83.95

-0.68 (-0.80%)

After Hours: $85.92 (+1.97, +2.35%)

Weekly Expected Move ±2.5%

$81 $84 $86 $88 $90

NASDAQ · Healthcare · Medical - Devices · Tech Score Sell · Power 48 · $1.1B mcap · 8M float · 1.49% daily turnover · Short 33% of daily vol

Credit Risk of going bust: not rated Debt: 0.0% of company value Bonds: none of note held by US funds details ▾

Not rated: no debt. Altman Z 52.34.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE

64.5 / 100

NoneWeakNarrowWide

Primary source: Cost Advantage · ROIC: 50.1% · 5Y Avg: 87.1%

Cost Advantage ★

Intangibles

Switching Cost

Network Effect

Scale

The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. IRMD has a Narrow competitive edge (64.5/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Cost Advantage. ROIC of 50.1% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets

Low

$106

Avg Target

$106

High

Based on 5 analyst ratings (12 mo)

Analyst Recommendations

Strong Buy: 0Buy: 2Hold: 0Sell: 0Strong Sell: 0

Rating Summary

ConsensusBuy

Avg Target$105.60

Analysts5

Price Target Change History

Date	Firm	Analyst	Old	New	Change	Upside @ Call	Stock@Call
2026-02-11	Lake Street	—	$100	$120	+20	+13.2%	$106.02
2026-02-10	Roth Capital	—	$98	$120	+22	+14.1%	$105.15
2025-11-03	Roth Capital	Kyle Bauser	$90	$98	+8	+16.5%	$84.11
2025-11-03	Lake Street	—	Initiated	$100	—	+18.9%	$84.11
2025-10-31	Roth Capital	Kyle Bauser	$60	$90	+30	+17.8%	$76.42
2024-08-02	Roth Capital	Jason Wittes	Initiated	$60	—	+30.0%	$46.15
2024-06-17	Loop Capital Markets	Frank Takkinen	Initiated	$60	—	+38.6%	$43.28

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

Oct 27, 2026

DCF

ROE

ROA

D/E

P/E

P/B

The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. IRMD receives an overall rating of B. Strongest factors: ROE (5/5), ROA (5/5). Areas of concern: D/E (1/5), P/E (1/5), P/B (1/5).

Rating Change History

Date	From	To
2026-02-19	C-	B
2026-02-11	B	C-
2026-01-14	B+	B
2026-01-03	B	B+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 77 Grade A+

Profitability

Balance Sheet

Earnings Quality

Growth

Value

Momentum

Safety

100

Cash Flow

The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. IRMD scores highest in Safety (100/100) and lowest in Value (36/100). An overall grade of A+ places IRMD among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score

59.05

Safe Zone

Piotroski F-Score

6/9

✓ ✓ ✓ ✓ ✗ ✓ ✗ ✗ ✓

Beneish M-Score

-2.56

Unlikely Manipulator

Ohlson O-Score

-13.40

Bankruptcy prob: 0.0%

Low Risk

Credit Rating

Score: 89.0/100

Trend: Stable

Earnings Quality

100/100

OCF/NI: 1.18x

Accruals: -3.7%

The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. IRMD scores 59.05, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. IRMD scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. IRMD's score of -2.56 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. IRMD's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. IRMD receives an estimated rating of AA (score: 89.0/100), with a stable trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). IRMD's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E

46.01x

PEG

3.95x

P/S

12.40x

P/B

10.52x

P/FCF

49.34x

P/OCF

45.32x

EV/EBITDA

37.64x

EV/Revenue

13.56x

EV/EBIT

40.03x

EV/FCF

46.97x

Earnings Yield

1.87%

FCF Yield

2.03%

Shareholder Yield

1.29%

Graham Number

$17.85

Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 46.0x earnings, IRMD is priced for high growth expectations. Graham's intrinsic value formula yields $17.85 per share, 374% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden

0.775

NI / EBT

Interest Burden

1.017

EBT / EBIT

EBIT Margin

0.339

EBIT / Rev

Asset Turnover

0.780

Rev / Assets

Equity Multiplier

1.129

Assets / Equity

ROE

23.5%

The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. IRMD's ROE of 23.5% is driven by Asset Turnover (0.780), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate

15.00%

Fair P/E

38.50x

Intrinsic Value

$68.96

Price/Value

1.39x

Margin of Safety

-38.58%

Premium

38.58%

Assessment

Neutral

Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with IRMD's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. IRMD actually compounded EPS at 15.8% over three years; the model uses 15%, the highest rate it will extrapolate — of 4,457 company-quarters that grew faster than 200%, none sustained it over the following seven years. IRMD trades at a 39% premium to its adjusted intrinsic value of $68.96, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 38.5x compares to the current market P/E of 46.0x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price

$83.95

Median 1Y

$95.03

5th Pctile

$48.08

95th Pctile

$188.08

Ann. Volatility

43.5%

25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

Executive	Salary	Stock	Total
Roger Susi President and Chief Executive Officer	$385,598	$—	$780,598
John Glenn Financial ancial Officer	$378,933	$—	$609,994
Jeffrey Chiprin Commercial ercial Officer	$205,000	$—	$529,360

CEO Pay Ratio

4:1

CEO-to-Employee Pay Ratio

CEO Total Comp: $780,598

Avg Employee Cost (SGA/emp): $212,060

Employees: 166

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees

166

+3.8% YoY

Revenue / Employee

$504,904

Rev: $83,814,000

Profit / Employee

$135,422

NI: $22,480,000

SGA / Employee

$212,060

Avg labor cost proxy

R&D / Employee

$17,922

Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
ROE	9.4%	14.0%	16.6%	18.6%	19.0%	17.6%	21.7%	21.8%	22.6%	23.7%	25.5%	25.1%	23.6%	24.3%	23.8%	23.7%	23.3%	24.8%	25.0%	23.5%	23.52%
ROA	8.2%	12.1%	14.4%	16.1%	16.5%	15.2%	18.6%	18.7%	19.6%	19.4%	21.9%	21.8%	20.5%	20.2%	20.9%	21.0%	20.3%	21.7%	21.8%	20.8%	20.82%
ROIC	54.4%	76.6%	74.3%	75.8%	78.7%	69.2%	54.5%	53.9%	50.2%	66.9%	50.0%	53.8%	52.6%	50.1%	45.1%	45.7%	46.8%	47.7%	51.9%	50.1%	50.05%
ROCE	10.2%	12.9%	16.8%	19.3%	19.6%	20.3%	24.0%	23.5%	24.1%	26.4%	25.8%	26.0%	24.7%	25.1%	24.9%	25.5%	25.9%	28.2%	29.5%	27.6%	27.64%
Gross Margin	77.1%	77.9%	76.2%	79.7%	78.6%	75.5%	75.7%	75.5%	77.8%	76.9%	76.1%	78.1%	77.4%	76.1%	76.1%	78.2%	77.8%	75.1%	76.5%	74.1%	74.07%
Operating Margin	28.3%	26.2%	25.0%	32.8%	30.8%	28.6%	25.9%	30.8%	35.8%	29.6%	27.0%	31.4%	31.6%	29.9%	27.8%	33.3%	32.2%	31.3%	32.9%	31.2%	31.23%
Net Margin	23.6%	32.8%	20.2%	25.5%	25.6%	24.7%	22.0%	25.9%	30.7%	26.0%	23.5%	27.3%	27.6%	26.5%	24.0%	28.3%	26.3%	28.4%	26.5%	25.5%	25.50%
EBITDA Margin	31.4%	29.4%	28.5%	36.6%	34.1%	24.0%	27.1%	31.9%	36.9%	30.7%	28.3%	32.5%	32.7%	33.7%	28.8%	38.8%	36.2%	37.0%	37.4%	33.2%	33.23%
FCF Margin	25.3%	25.2%	23.9%	17.9%	17.5%	15.3%	9.3%	12.0%	7.5%	8.3%	15.9%	18.7%	24.1%	22.9%	18.6%	17.5%	17.8%	20.1%	27.9%	28.9%	28.88%
OCF Margin	27.0%	26.9%	26.1%	20.5%	20.6%	18.8%	23.5%	25.3%	20.0%	20.5%	18.8%	22.8%	33.0%	35.0%	34.6%	35.0%	31.1%	29.8%	33.5%	31.4%	31.43%
ROE 3Y Avg	snapshot only																				22.66%
ROE 5Y Avg	snapshot only																				21.55%
ROA 3Y Avg	snapshot only																				20.06%
ROIC 3Y Avg	snapshot only																				52.59%
ROIC Economic	snapshot only																				21.35%
Cash ROA	snapshot only																				23.60%
Cash ROIC	snapshot only																				63.60%
CROIC	snapshot only																				58.43%
NOPAT Margin	snapshot only																				24.74%
Pretax Margin	snapshot only																				34.45%
R&D / Revenue	snapshot only																				3.57%
SGA / Revenue	snapshot only																				40.37%
SBC / Revenue	snapshot only																				2.53%

Valuation

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
P/E Ratio	63.74	57.22	50.77	32.78	27.14	25.97	34.91	39.75	33.27	34.29	30.51	29.42	33.87	35.98	33.59	36.78	42.89	55.72	52.47	53.35	46.008
P/S Ratio	10.05	12.76	11.79	8.36	7.04	6.25	8.50	9.75	8.63	8.99	8.08	7.89	8.85	9.45	8.84	9.79	11.28	14.94	14.36	14.25	12.401
P/B Ratio	5.70	7.39	8.46	6.07	5.07	4.52	7.46	8.46	7.28	8.25	7.18	6.88	7.56	7.97	7.38	8.06	9.24	13.24	12.58	12.09	10.521
P/FCF	39.79	50.74	49.24	46.70	40.30	40.78	91.32	81.39	114.47	108.02	50.76	42.17	36.77	41.18	47.47	56.06	63.55	74.53	51.41	49.34	49.338
P/OCF	37.25	47.40	45.08	40.76	34.14	33.17	36.19	38.57	43.14	43.78	43.05	34.65	26.79	27.01	25.52	27.99	36.33	50.21	42.80	45.32	45.325
EV/EBITDA	37.87	42.19	38.08	23.19	18.53	17.02	25.89	30.93	26.25	26.05	23.33	22.47	26.16	27.44	25.62	27.11	30.69	40.54	36.69	37.64	37.638
EV/Revenue	8.58	11.33	10.71	7.32	5.98	5.20	7.78	9.02	7.92	8.26	7.44	7.20	8.13	8.74	8.17	9.10	10.58	14.33	13.70	13.56	13.562
EV/EBIT	44.86	48.24	43.25	26.05	20.76	17.75	26.54	31.13	26.06	27.04	24.24	23.33	27.17	28.43	26.48	28.39	32.27	43.14	39.17	40.03	40.035
EV/FCF	33.96	45.03	44.72	40.88	34.23	33.96	83.63	75.31	105.07	99.28	46.75	38.47	33.77	38.08	43.88	52.15	59.60	71.48	49.07	46.97	46.969
Earnings Yield	1.6%	1.7%	2.0%	3.1%	3.7%	3.9%	2.9%	2.5%	3.0%	2.9%	3.3%	3.4%	3.0%	2.8%	3.0%	2.7%	2.3%	1.8%	1.9%	1.9%	1.87%
FCF Yield	2.5%	2.0%	2.0%	2.1%	2.5%	2.5%	1.1%	1.2%	0.9%	0.9%	2.0%	2.4%	2.7%	2.4%	2.1%	1.8%	1.6%	1.3%	1.9%	2.0%	2.03%
PEG Ratio	snapshot only																				3.947
Price/Tangible Book	snapshot only																				12.512
EV/OCF	snapshot only																				43.148
EV/Gross Profit	snapshot only																				17.877
Acquirers Multiple	snapshot only																				42.495
Shareholder Yield	snapshot only																				1.29%
Graham Number	snapshot only																				$17.85

Leverage & Solvency

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Current Ratio	11.33	11.18	10.48	11.16	12.83	9.06	9.07	8.71	9.13	4.65	9.44	9.87	9.21	8.84	8.87	8.78	6.64	7.98	7.13	9.46	9.463
Quick Ratio	10.63	10.54	9.79	10.37	11.89	8.43	8.14	7.60	7.65	3.87	7.77	8.25	7.82	7.62	7.62	7.51	5.72	6.84	6.15	8.13	8.126
Debt/Equity	0.04	0.03	0.04	0.04	0.03	0.03	0.04	0.03	0.03	0.03	0.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.000
Net Debt/Equity	-0.84	-0.83	-0.78	-0.76	-0.76	-0.76	-0.63	-0.63	-0.60	-0.67	-0.57	-0.60	-0.62	-0.60	-0.56	-0.56	-0.57	-0.54	-0.57	-0.58	-0.581
Debt/Assets	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.02	0.02	0.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.000
Debt/EBITDA	0.29	0.22	0.19	0.16	0.14	0.14	0.14	0.13	0.11	0.10	0.09	0.02	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.000
Net Debt/EBITDA	-6.51	-5.35	-3.84	-3.30	-3.28	-3.42	-2.38	-2.49	-2.35	-2.29	-2.00	-2.16	-2.32	-2.23	-2.10	-2.03	-2.04	-1.73	-1.75	-1.90	-1.899
Interest Coverage	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Equity Multiplier	1.15	1.15	1.16	1.15	1.14	1.16	1.18	1.18	1.17	1.29	1.16	1.13	1.13	1.13	1.13	1.13	1.17	1.15	1.16	1.13	1.130
Cash Ratio	snapshot only																				6.447
Defensive Interval	snapshot only																				695.2 days

Efficiency & Turnover

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Asset Turnover	0.52	0.54	0.62	0.63	0.64	0.63	0.76	0.76	0.75	0.74	0.83	0.81	0.79	0.77	0.79	0.79	0.77	0.81	0.80	0.78	0.780
Inventory Turnover	2.05	2.37	2.34	2.28	2.27	2.49	2.41	2.14	1.77	1.69	1.67	1.55	1.42	1.45	1.49	1.54	1.61	1.77	1.78	1.78	1.777
Receivables Turnover	9.05	8.61	8.11	7.80	6.75	5.79	6.26	6.15	5.37	5.14	5.51	6.03	6.16	6.43	5.84	6.79	6.65	6.92	6.61	7.16	7.161
Payables Turnover	13.00	13.56	12.01	14.28	12.18	9.31	8.88	8.42	8.01	8.43	10.43	8.62	7.79	9.00	8.95	11.84	9.89	10.49	8.38	11.11	11.114
DSO	40	42	45	47	54	63	58	59	68	71	66	61	59	57	62	54	55	53	55	51	51.0 days
DIO	178	154	156	160	161	147	151	171	206	216	219	236	257	251	245	237	227	206	205	205	205.4 days
DPO	28	27	30	26	30	39	41	43	46	43	35	42	47	41	41	31	37	35	44	33	32.8 days
Cash Conversion Cycle	190	169	170	181	185	171	169	186	228	243	250	254	269	267	266	260	245	224	217	224	223.6 days
Fixed Asset Turnover	snapshot only																				3.567
Operating Cycle	snapshot only																				256.4 days
Cash Velocity	snapshot only																				1.461
Capital Intensity	snapshot only																				1.332

Growth (YoY)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue	13.0%	31.8%	39.2%	35.5%	30.7%	27.5%	25.8%	25.2%	25.2%	23.0%	19.9%	16.0%	13.2%	11.7%	11.0%	11.7%	12.9%	14.4%	14.8%	11.2%	11.21%
Net Income	52.8%	5.8%	9.6%	1.7%	1.1%	37.6%	31.9%	20.4%	25.1%	34.0%	30.4%	26.9%	14.1%	11.9%	10.4%	10.8%	13.7%	16.9%	19.3%	11.6%	11.60%
EPS	51.4%	5.7%	9.5%	1.7%	1.1%	37.6%	31.5%	19.6%	24.1%	32.8%	29.7%	26.6%	13.7%	11.5%	9.7%	10.2%	13.0%	16.0%	18.9%	11.2%	11.24%
FCF	49.4%	1.0%	1.2%	9.9%	-9.6%	-22.3%	-51.1%	-16.2%	-46.0%	-33.2%	1.0%	81.3%	2.6%	2.1%	29.9%	4.2%	-16.7%	-0.0%	72.2%	84.0%	83.97%
EBITDA	3.1%	18.3%	6.8%	1.4%	86.2%	45.2%	34.5%	15.7%	17.0%	27.6%	27.1%	27.4%	16.6%	12.1%	11.1%	17.1%	25.3%	27.0%	34.4%	19.3%	19.33%
Op. Income	7.8%	14.0%	38.2%	1.7%	96.8%	59.2%	49.0%	29.2%	32.1%	28.2%	25.5%	23.5%	11.5%	9.6%	9.0%	11.0%	16.5%	19.0%	23.4%	15.7%	15.74%
OCF Growth	snapshot only																				-0.01%
Asset Growth	snapshot only																				8.01%
Equity Growth	snapshot only																				7.90%
Shares Change	snapshot only																				0.32%
Dividend Growth	snapshot only																				94.20%

Growth (CAGR)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue 3Y	10.1%	11.2%	12.2%	12.5%	11.8%	11.4%	13.4%	18.1%	22.7%	27.4%	28.0%	25.3%	22.8%	20.5%	18.7%	17.5%	17.0%	16.3%	15.2%	13.0%	12.98%
Revenue 5Y	1.7%	5.2%	9.4%	14.4%	17.6%	18.2%	17.7%	17.4%	16.9%	16.6%	16.3%	15.6%	14.7%	13.7%	14.2%	16.4%	18.8%	21.5%	21.7%	19.6%	19.60%
EPS 3Y	7.1%	12.7%	11.3%	13.6%	16.2%	9.2%	11.9%	37.6%	59.1%	1.3%	1.6%	59.0%	44.6%	26.8%	23.3%	18.6%	16.8%	19.8%	19.2%	15.8%	15.77%
EPS 5Y	-7.6%	3.7%	13.5%	32.0%	52.5%	88.8%	52.2%	40.1%	26.7%	21.2%	18.7%	17.3%	17.3%	14.0%	14.8%	29.4%	39.0%	74.0%	87.7%	37.5%	37.54%
Net Income 3Y	8.3%	13.9%	12.6%	14.9%	17.2%	10.0%	12.9%	40.0%	60.2%	1.3%	1.6%	59.8%	45.3%	27.3%	23.8%	19.2%	17.5%	20.6%	19.8%	16.2%	16.22%
Net Income 5Y	-6.5%	5.3%	17.3%	34.0%	55.0%	91.4%	54.3%	41.7%	27.8%	22.2%	19.7%	18.3%	18.1%	14.8%	15.7%	31.0%	39.8%	75.0%	88.7%	38.2%	38.23%
EBITDA 3Y	10.9%	16.4%	18.5%	22.3%	18.7%	17.0%	22.4%	64.6%	1.1%	2.3%	1.4%	51.5%	36.5%	27.6%	23.8%	20.0%	19.6%	22.1%	23.8%	21.2%	21.21%
EBITDA 5Y	-7.6%	0.2%	11.2%	28.3%	50.7%	54.4%	37.0%	27.1%	24.3%	24.0%	23.3%	22.0%	17.9%	18.1%	21.0%	46.1%	67.4%	1.2%	82.1%	37.2%	37.17%
Gross Profit 3Y	10.1%	11.3%	12.4%	12.8%	12.1%	11.6%	13.6%	18.7%	23.8%	28.6%	28.9%	26.4%	23.4%	20.7%	18.9%	17.1%	16.4%	15.9%	15.0%	12.8%	12.77%
Gross Profit 5Y	0.2%	4.0%	8.5%	14.3%	18.1%	18.7%	17.9%	17.3%	16.9%	16.6%	16.5%	15.7%	14.5%	13.7%	14.2%	16.9%	19.7%	22.2%	22.4%	19.8%	19.77%
Op. Income 3Y	12.2%	17.8%	20.0%	23.5%	20.9%	21.8%	28.1%	89.1%	1.8%	—	3.2%	61.9%	42.6%	30.8%	26.8%	21.0%	19.7%	18.7%	19.1%	16.7%	16.66%
Op. Income 5Y	-10.4%	-2.1%	9.1%	26.3%	51.9%	64.8%	44.7%	34.4%	29.7%	27.3%	26.4%	24.6%	21.1%	20.5%	23.5%	56.1%	97.3%	—	1.5%	40.4%	40.37%
FCF 3Y	25.4%	13.9%	20.5%	6.4%	-2.5%	-5.7%	-19.7%	-4.8%	-10.0%	1.8%	29.3%	18.6%	20.8%	16.9%	9.2%	16.5%	17.6%	27.2%	66.1%	51.5%	51.47%
FCF 5Y	2.7%	5.9%	14.3%	12.3%	22.6%	25.8%	2.9%	4.0%	-0.8%	-5.2%	11.9%	12.8%	12.6%	11.5%	6.7%	10.3%	17.0%	26.5%	37.1%	26.2%	26.20%
OCF 3Y	25.7%	15.1%	22.1%	9.8%	1.8%	-0.6%	7.2%	18.6%	20.1%	32.3%	31.7%	23.8%	31.4%	31.5%	30.4%	40.4%	34.1%	35.4%	29.7%	21.5%	21.48%
OCF 5Y	1.3%	3.7%	11.6%	11.3%	19.6%	24.1%	20.7%	18.7%	19.2%	12.8%	14.5%	16.4%	19.1%	20.2%	19.3%	24.5%	28.0%	33.8%	39.1%	26.6%	26.60%
Assets 3Y	18.8%	19.6%	10.0%	10.0%	8.3%	8.6%	3.4%	5.8%	7.5%	9.0%	6.8%	6.0%	6.3%	5.9%	12.0%	12.0%	13.0%	8.4%	14.8%	12.2%	12.19%
Assets 5Y	17.2%	17.4%	14.1%	15.5%	16.0%	17.0%	13.4%	13.7%	13.3%	13.7%	10.1%	9.6%	8.5%	8.1%	8.3%	9.1%	10.3%	8.9%	9.6%	8.8%	8.75%
Equity 3Y	19.2%	19.8%	11.9%	11.8%	10.5%	9.9%	3.5%	5.7%	7.1%	5.2%	6.5%	7.1%	7.1%	6.4%	12.9%	12.7%	12.1%	8.7%	15.3%	13.8%	13.82%
Book Value 3Y	17.9%	18.5%	10.6%	10.6%	9.5%	9.1%	2.6%	3.9%	6.4%	4.6%	5.8%	6.5%	6.6%	5.9%	12.4%	12.1%	11.5%	8.0%	14.7%	13.4%	13.38%
Dividend 3Y	—	—	—	—	—	—	0.9%	-0.0%	1.1%	1.1%	-16.0%	-9.8%	-4.2%	0.7%	-0.9%	-6.8%	-11.2%	2.5%	24.6%	24.4%	24.41%

Growth Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue Stability	0.15	0.35	0.62	0.86	0.88	0.81	0.81	0.87	0.87	0.85	0.86	0.88	0.89	0.90	0.94	0.98	1.00	1.00	0.99	0.99	0.990
Earnings Stability	0.00	0.05	0.15	0.54	0.59	0.46	0.42	0.67	0.65	0.51	0.49	0.73	0.77	0.68	0.69	0.94	0.96	0.95	0.94	0.94	0.943
Margin Stability	0.96	0.97	0.98	0.98	0.98	0.98	0.99	0.99	0.98	0.98	0.99	0.99	0.99	1.00	1.00	0.99	0.98	0.98	0.99	0.99	0.990
Rev. Growth Consistency	0.50	0.50	0.50	0.50	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.000
Earn. Growth Consistency	0.50	0.50	0.50	0.50	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.000
FCF Positive Streak	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
Earnings Persistence	0.50	0.50	0.50	0.50	0.50	0.85	0.87	0.92	0.90	0.86	0.88	0.89	0.94	0.95	0.96	0.96	0.95	0.93	0.92	0.95	0.954
Earnings Smoothness	0.58	0.00	0.00	0.09	0.27	0.68	0.73	0.81	0.78	0.71	0.74	0.76	0.87	0.89	0.90	0.90	0.87	0.84	0.82	0.89	0.890
ROE Trend	-0.02	0.03	0.08	0.10	0.11	0.10	0.12	0.09	0.08	0.09	0.05	0.04	0.02	0.01	-0.00	-0.00	-0.01	0.01	0.01	0.00	0.000
Gross Margin Trend	0.00	0.01	0.01	0.02	0.03	0.02	0.02	-0.00	-0.01	-0.01	-0.00	0.00	-0.00	-0.00	0.00	0.00	0.00	0.00	0.00	-0.01	-0.012
FCF Margin Trend	0.03	0.04	0.03	-0.05	-0.05	-0.05	-0.10	-0.08	-0.14	-0.12	-0.01	0.04	0.12	0.11	0.06	0.02	0.02	0.04	0.11	0.11	0.108
Sustainable Growth Rate	9.4%	14.0%	-3.4%	-0.6%	0.7%	0.4%	0.8%	2.2%	4.3%	5.5%	14.2%	11.8%	8.7%	7.0%	14.3%	14.4%	14.1%	8.2%	8.7%	7.4%	7.37%
Internal Growth Rate	8.9%	13.8%	—	—	0.6%	0.3%	0.7%	1.9%	3.9%	4.7%	13.8%	11.4%	8.2%	6.2%	14.4%	14.6%	14.0%	7.7%	8.2%	7.0%	6.98%

Cash Flow Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
OCF/Net Income	1.71	1.21	1.13	0.80	0.79	0.78	0.96	1.03	0.77	0.78	0.71	0.85	1.26	1.33	1.32	1.31	1.18	1.11	1.23	1.18	1.177
FCF/OCF	0.94	0.93	0.92	0.87	0.85	0.81	0.40	0.47	0.38	0.41	0.85	0.82	0.73	0.66	0.54	0.50	0.57	0.67	0.83	0.92	0.919
FCF/Net Income	snapshot only																				1.081
OCF/EBITDA	snapshot only																				0.872
CapEx/Revenue	1.7%	1.8%	2.2%	2.6%	3.1%	3.5%	14.2%	13.3%	12.5%	12.2%	2.8%	4.1%	9.0%	12.0%	16.0%	17.5%	13.3%	9.7%	5.6%	2.6%	2.56%
CapEx/Depreciation	snapshot only																				1.185
Accruals Ratio	-0.06	-0.03	-0.02	0.03	0.03	0.03	0.01	-0.01	0.04	0.04	0.06	0.03	-0.05	-0.07	-0.07	-0.07	-0.04	-0.02	-0.05	-0.04	-0.037
Sloan Accruals	snapshot only																				0.064
Cash Flow Adequacy	snapshot only																				1.505
Earnings Quality Score	snapshot only																				1.000

Dividends & Buybacks

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Dividend Yield	0.0%	0.0%	2.4%	3.1%	3.5%	3.8%	2.8%	2.3%	2.4%	2.2%	1.5%	1.8%	1.9%	2.0%	1.2%	1.1%	0.9%	1.2%	1.2%	1.3%	1.52%
Dividend/Share	$0.00	$0.00	$0.99	$0.99	$0.99	$0.99	$1.04	$1.04	$1.04	$1.04	$0.63	$0.77	$0.92	$1.07	$0.61	$0.63	$0.65	$1.17	$1.20	$1.23	$1.27
Payout Ratio	0.0%	0.0%	1.2%	1.0%	96.3%	97.9%	96.2%	90.0%	81.0%	76.9%	44.5%	53.0%	63.2%	71.1%	39.7%	39.3%	39.6%	66.9%	65.4%	68.7%	68.66%
FCF Payout Ratio	0.0%	0.0%	1.2%	1.5%	1.4%	1.5%	2.5%	1.8%	2.8%	2.4%	74.0%	75.9%	68.6%	81.4%	56.2%	60.0%	58.7%	89.5%	64.0%	63.5%	63.49%
Total Payout Ratio	0.0%	0.0%	1.2%	1.0%	96.3%	97.9%	96.2%	90.0%	81.0%	76.9%	44.5%	53.0%	63.2%	71.1%	39.7%	39.3%	39.6%	66.9%	65.4%	68.7%	68.66%
Div. Increase Streak	—	—	0	0	0	0	1	1	1	1	0	0	0	1	0	0	0	1	0	0	0
Chowder Number	—	—	—	—	—	—	0.08	0.08	0.08	0.08	-0.38	-0.24	-0.09	0.05	-0.00	-0.17	-0.28	0.11	0.98	0.96	0.961
Buyback Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Net Buyback Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	-0.0%	-0.0%	-0.0%	-0.0%	0.0%	0.0%	0.0%	0.00%
Total Shareholder Return	0.0%	0.0%	2.4%	3.1%	3.5%	3.8%	2.8%	2.3%	2.4%	2.2%	1.5%	1.8%	1.9%	2.0%	1.2%	1.1%	0.9%	1.2%	1.2%	1.3%	1.29%

DuPont Factors

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Tax Burden (NI/EBT)	0.82	0.95	0.94	0.91	0.89	0.79	0.79	0.79	0.79	0.79	0.79	0.79	0.79	0.79	0.79	0.79	0.79	0.79	0.78	0.78	0.775
Interest Burden (EBT/EBIT)	1.00	1.00	1.00	1.00	1.01	1.04	1.05	1.07	1.09	1.08	1.09	1.10	1.11	1.08	1.08	1.05	1.02	1.02	1.00	1.02	1.017
EBIT Margin	0.19	0.23	0.25	0.28	0.29	0.29	0.29	0.29	0.30	0.31	0.31	0.31	0.30	0.31	0.31	0.32	0.33	0.33	0.35	0.34	0.339
Asset Turnover	0.52	0.54	0.62	0.63	0.64	0.63	0.76	0.76	0.75	0.74	0.83	0.81	0.79	0.77	0.79	0.79	0.77	0.81	0.80	0.78	0.780
Equity Multiplier	1.16	1.15	1.15	1.16	1.15	1.15	1.17	1.16	1.16	1.22	1.16	1.15	1.15	1.20	1.14	1.13	1.15	1.14	1.15	1.13	1.129

Per Share

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
EPS (Diluted TTM)	$0.48	$0.74	$0.82	$0.97	$1.03	$1.02	$1.08	$1.15	$1.28	$1.35	$1.41	$1.46	$1.46	$1.50	$1.54	$1.61	$1.65	$1.75	$1.83	$1.79	$1.79
Book Value/Share	$5.39	$5.71	$4.94	$5.22	$5.52	$5.83	$5.07	$5.42	$5.85	$5.61	$5.97	$6.24	$6.53	$6.79	$7.02	$7.35	$7.65	$7.35	$7.65	$7.90	$7.96
Tangible Book/Share	$5.30	$5.62	$4.84	$5.09	$5.37	$5.67	$4.90	$5.24	$5.66	$5.41	$5.76	$6.03	$6.30	$6.55	$6.77	$7.09	$7.39	$7.09	$7.40	$7.64	$7.64
Revenue/Share	$3.05	$3.31	$3.55	$3.78	$3.98	$4.22	$4.45	$4.71	$4.94	$5.15	$5.31	$5.45	$5.58	$5.73	$5.86	$6.05	$6.26	$6.51	$6.70	$6.71	$6.75
FCF/Share	$0.77	$0.83	$0.85	$0.68	$0.70	$0.65	$0.41	$0.56	$0.37	$0.43	$0.84	$1.02	$1.34	$1.31	$1.09	$1.06	$1.11	$1.31	$1.87	$1.94	$1.95
OCF/Share	$0.82	$0.89	$0.93	$0.78	$0.82	$0.80	$1.05	$1.19	$0.99	$1.06	$1.00	$1.24	$1.84	$2.00	$2.03	$2.12	$1.94	$1.94	$2.25	$2.11	$2.12
Cash/Share	$4.71	$4.95	$4.03	$4.13	$4.40	$4.59	$3.37	$3.60	$3.67	$3.91	$3.54	$3.80	$4.05	$4.09	$3.92	$4.13	$4.40	$3.97	$4.38	$4.59	$4.62
EBITDA/Share	$0.69	$0.89	$1.00	$1.19	$1.29	$1.29	$1.34	$1.37	$1.49	$1.63	$1.69	$1.74	$1.73	$1.82	$1.87	$2.03	$2.16	$2.30	$2.50	$2.42	$2.42
Debt/Share	$0.20	$0.20	$0.19	$0.19	$0.18	$0.17	$0.19	$0.18	$0.17	$0.16	$0.15	$0.03	$0.02	$0.01	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Net Debt/Share	$-4.50	$-4.75	$-3.83	$-3.94	$-4.22	$-4.42	$-3.19	$-3.42	$-3.50	$-3.75	$-3.39	$-3.78	$-4.03	$-4.07	$-3.92	$-4.13	$-4.40	$-3.97	$-4.38	$-4.59	$-4.59

Academic Models

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Altman Z-Score	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	59.051
Altman Z-Prime	snapshot only																				105.769
Piotroski F-Score	7	7	6	7	7	6	5	6	5	6	7	7	7	7	7	7	7	6	7	6	6
Beneish M-Score	-2.68	-2.46	-2.16	-1.38	-1.00	-0.84	-1.67	-1.95	-1.92	-2.20	-1.95	-2.20	-2.80	-2.79	-2.69	-2.79	-2.34	-2.47	-2.77	-2.56	-2.555
Ohlson O-Score	snapshot only																				-13.395
ROIC (Greenblatt)	snapshot only																				28.74%
Net-Net WC	snapshot only																				$5.71
EVA	snapshot only																				$17090494.38

Credit

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Credit Rating	snapshot only																				AA
Credit Score	92.73	93.11	93.20	93.48	93.62	94.50	93.11	93.88	93.57	93.53	93.28	93.63	93.27	93.41	93.47	89.00	89.00	89.00	89.00	89.00	89.000
Credit Grade	snapshot only																				3
Credit Trend	snapshot only																				0.000
Implied Spread (bps)	snapshot only																				80.000
Industry Credit Rank	snapshot only																				86
Sector Credit Rank	snapshot only																				87

IRMD NASDAQ

Edge Score

Analyst Insights

Financial Rating

InsiderStreet Scorecard

Risk & Quality Signals

Valuation

DuPont Decomposition (5-Factor)

Graham-Dodd Adjusted Valuation

Profitability Trends

Leverage & Solvency Trends

Efficiency & Working Capital Trends

Growth Trends (YoY %)

Earnings Stability

Monte Carlo Price Simulation

Executive Compensation

C-Suite Compensation

CEO Pay Ratio

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Scaling Efficiency

Sign in to InsiderStreet